These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1070 related items for PubMed ID: 19539481

  • 1. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem; 2009 Jul 15; 17(14):4894-9. PubMed ID: 19539481
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.
    Davis RA, Innocenti A, Poulsen SA, Supuran CT.
    Bioorg Med Chem; 2010 Jan 01; 18(1):14-8. PubMed ID: 19962903
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Parkkila S, Hilvo M, Supuran CT.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9113-20. PubMed ID: 18819811
    [Abstract] [Full Text] [Related]

  • 6. (R)-/(S)-10-camphorsulfonyl-substituted aromatic/heterocyclic sulfonamides selectively inhibit mitochondrial over cytosolic carbonic anhydrases.
    Maresca A, Supuran CT.
    Bioorg Med Chem Lett; 2011 Mar 01; 21(5):1334-7. PubMed ID: 21300547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5775-80. PubMed ID: 15501039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F, Garaj V, Maresca A, Wagner J, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT.
    Bioorg Med Chem; 2011 May 15; 19(10):3105-19. PubMed ID: 21515057
    [Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT.
    J Med Chem; 2005 Dec 01; 48(24):7860-6. PubMed ID: 16302824
    [Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F, Innocenti A, Sławiński J, Kornicka A, Brzozowski Z, Pomarnacka E, Scozzafava A, Temperini C, Supuran CT.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3933-40. PubMed ID: 18242998
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
    Innocenti A, Antel J, Wurl M, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Nov 15; 14(22):5703-7. PubMed ID: 15482952
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors: the inhibition profiles of the human mitochondrial isoforms VA and VB with anions are very different.
    Nishimori I, Innocenti A, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2007 Nov 01; 15(21):6742-7. PubMed ID: 17761422
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
    Ozensoy O, Nishimori I, Vullo D, Puccetti L, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2005 Nov 15; 13(22):6089-93. PubMed ID: 16006130
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK, Verma SM, Tanç M, Carta F, Supuran CT.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5168-74. PubMed ID: 23867389
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.
    Poulsen SA, Wilkinson BL, Innocenti A, Vullo D, Supuran CT.
    Bioorg Med Chem Lett; 2008 Aug 15; 18(16):4624-7. PubMed ID: 18644716
    [Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL, Innocenti A, Puccetti L, Manole G, Barbuceanu S, Saramet I, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2347-52. PubMed ID: 15837323
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O, Temperini C, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem Lett; 2008 Jan 01; 18(1):152-8. PubMed ID: 18024029
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.